RxDoctor Payments Data

Wayne Shaia, MD

Otolaryngology · Richmond, VANPI 1356335947

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,425 of the $11,580 with a category attached, or 64.1%. Medical Device Business Services, Inc. accounts for 67.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $5,460 and has fallen 80.4% since, to $1,069 in 2025. Among otolaryngology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,580in general payments, 2019–2025

Across 68 payments — averaging $170.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$8K
  • Aerin Medical Inc.$2K
  • Regeneron Healthcare Solutions, Inc.$748
  • Cochlear Americas$366
  • Sanofi$247
  • Advanced Bionics, LLC$217
  • plus $472 from 7 others

What the payments were for

  • Consulting fees$7,42564%
  • Travel & lodging$3523%
  • Food & beverage$3,80333%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,580 in reported general payments places this provider in the 95th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia

Medicare billing

Part B allowed, 2024
$547,055
Medicare patients
1,836
Services billed
5,104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl104$1,908
Betamethasone Valerate30$1,290
Ipratropium Bromide29$1,249
Ofloxacin29$1,247
Nortriptyline Hcl70$1,213
Cefdinir88$972
Meclizine Hcl68$686
Clonazepam150$667
Ondansetron OdtOndansetron68$647
Omeprazole47$551
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav53$485
Diazepam55$388
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$376
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$323
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid38$309

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →